2015-02-27 22:03:34 UTC

2015 James W. Freston Conference: A Look at Session One

March 5, 2015

We're revealing details of what you can expect at session one of the 2015 meeting, which will focus on IBS.

The AGA Institute is excited to bring you details from the faculty for the upcoming 2015 James W. Freston Conference, which will take place Aug. 29 and 30 in Chicago. Over the next few weeks, we’ll highlight sessions from the conference and provide you with insight on what you can expect to be addressed. This week, let’s take a look at session one.

Setting the Stage for the Renaissance of IBS and Moving Beyond
The 2015 conference kicks things off with concepts that have led to a renewal in how researchers and clinicians approach understanding and managing IBS. This includes its economic burden on populations worldwide to implications for diagnostic and therapeutic advances in IBS. Specifically, attendees will be able to:

  • Examine the impact of IBS globally, including gender prevalence, subtype and natural history of IBS.
  • Discuss the Rome Criteria for IBS and how it can be customized to implement a multi-dimensional clinical profile used for individualized treatment.
  • Identify the cause of bowel dysfunction and how treating it may relieve other symptoms in patients with IBS.

Be sure to check the April 2 issue of AGA eDigest for details on session two. To view the program in its entirety, visit www.gastro.org/frestonibs.

Funded by the Takeda Endowment in support of the James W. Freston Single Topic Conference.

More on Irritable Bowel Syndrome

Principles of GI for the NP and PA

Aug. 10, 2018

Hear from the experts as they provide you with critical updates on treating and managing patients with a variety of GI disorders.

2018 AGA Postgraduate Course

June 2, 2018

Secure your spot for this clinically focused, multi-topic course that offers immediately applicable information. Held in conjunction with DDW®. Save $75 when you register by April 18.

Vitamin D supplements show promise for easing IBS

April 19, 2018

Many irritable bowel syndrome (IBS) patients deficient in this pivotal vitamin, which may affect GI immune system, gut motility and serotonin metabolism.